Profil bibliographique

Thapas Nagarajan

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

55Publications signalées

6469Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19Chronic Obstructive Pulmonary Disease (COPD) ResearchLung Cancer Diagnosis and Treatment

Publications récentes

Accès ouvert 2026 article

Medical thoracoscopy with talc poudrage and indwelling pleural catheter insertion versus medical thoracoscopy with talc poudrage alone for patients with symptomatic malignant pleural effusion (TACTIC): a randomised, controlled phase 3 trial

A Dipper, Anand Sundaralingam, Emma Hedley, Sharada Gudur et autres

3 citationsThe Lancet Respiratory Medicine

2025 conference-abstract

S136 Implementation of the BTS clinical statement on pulmonary rehabilitation 2023: evidence from a community COPD service

Jean D. Kinsey, Thapas Nagarajan, Dave Singh, Augusta Beech

0 citations

2025 conference-abstract

S150 REDUCE 2: a randomised feasibility study comparing recurrent therapeutic thoracentesis to indwelling pleural catheter insertion, daily drainage and talc instillation for the management of medically-resistant cardiogenic pleural effusions

H Welch, Steven Walker, E Tucker, S Patoole et autres

0 citations

2025 conference-paper

S2 What is the clinical effectiveness and cost-effectiveness of nebulised 7% saline in patients with chronic obstructive pulmonary disease (COPD)- (MucAct COPD Trial)

AT Hill, Steff Lewis, Sharon Tuck, A Skeikh et autres

1 citation

2025 conference-abstract

P154 Blood eosinophil counts and escalation to high dose ICS, in COPD patients from a community service

Augusta Beech, Zachary Patterson, Robert Danby, Thapas Nagarajan et autres

0 citations

Accès ouvert 2025 article

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Amr E. Abbas, Fatima Abbas, Kaja Abbas et autres

0 citationsThe Lancet Infectious Diseases

Accès ouvert 2025 article

Does a Raised Serum Troponin During a Severe Chronic Obstructive Pulmonary Disease Exacerbation Predict Future Cardiovascular Events?

Nyle Cockell, Nihal Billing, Praanesh Kumareshan, Thapas Nagarajan

1 citationCureus

2024 conference-abstract

Initiation of single- and multiple-inhaler triple therapy for COPD and adoption of budesonide/glycopyrrolate/formoterol (BGF): insights from primary care in England - the AURA UK study

Scott Dickinson, Thapas Nagarajan, Ruiqi Zhang, Michael Pollack et autres

0 citations

2024 conference-abstract

Does raised troponin during severe COPD exacerbation predict future cardiovascular events?

Nyle Cockell, Nihal Billing, Praanesh Kumareshan, Holly Cook et autres

0 citations

Accès ouvert 2024 erratum

Author Correction: Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses

Benedict Michael, Cordelia Dunai, Edward Needham, Kukatharmini Tharmaratnam et autres

0 citationsNature Communications

Accès ouvert 2024 article

Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease

Felicity Liew, Claudia Efstathiou, Sara Fontanella, Matthew Richardson et autres

102 citationsNature Immunology

Accès ouvert 2024 article

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Peter Sandercock, Janet Darbyshire, David L. DeMets, Robert Fowler et autres

11 citationsNature Communications

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.